Streetbeat News

Analyst Ratings

BASE

DA Davidson analyst Rudy Kessinger has maintained a Buy rating on Couchbase (NASDAQ:BASE) and increased the price target from $27 to $35.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:30 pm

CERS

Cantor Fitzgerald analyst Ross Osborn reiterated an Overweight rating on Cerus (NASDAQ:CERS) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:29 pm

FERG

Truist Securities analyst Keith Hughes has maintained a Buy rating on Ferguson (NYSE:FERG) and increased the price target from $197 to $230.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:29 pm

NPCE

Cantor Fitzgerald analyst Ross Osborn maintains an Overweight rating on NeuroPace (NASDAQ:NPCE) and raises the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:28 pm

AGS

Truist Securities analyst Barry Jonas has maintained a Buy rating on PlayAGS (NYSE:AGS) and increased the price target from $12 to $13.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:27 pm

CHPT

DA Davidson analyst Matt Summerville maintains a Buy rating on ChargePoint Holdings (CHPT) and sets a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:27 pm

TGT

Truist Securities analyst Scot Ciccarelli maintains a Hold rating on Target Corporation (TGT) and raises the price target from $142 to $160.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:26 pm

TDOC

Truist Securities analyst Jailendra Singh has maintained a Hold rating on Teladoc Health (TDOC) and reduced the price target from $23 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:25 pm

KHTRF

Raymond James analyst David Novak has maintained an Outperform rating on Knight Therapeutics (OTC:KHTRF) and raised the price target from $7 to $7.5.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:23 pm

BIRDF

Raymond James analyst Frederic Bastien maintains an Outperform rating on Bird Construction (BIRDF) and raises the price target from $18.5 to $20.5.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:20 pm